Skip to search formSkip to main contentSkip to account menu

Berubicin

Known as: (8S,10S)-10-((3-Amino-4-O-Benzyl-2,3,6-Trideoxy-A-L-Lyxo-Hexopyranosyl)Oxy)-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-7,8,9,10-Tetrahydrotetracene-5,12-Dione, 5,12-Naphthacenedione, 10-((3-Amino-2,3,6-Trideoxy-4-O-(Phenylmethyl)-Alpha-L-Lyxo-Hexopyranosyl)Oxy)-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-, (8S,10S)- 
A 4'-O-benzylated analogue of the anthracycline derivative doxorubicin, with potential antineoplastic activity. Berubicin intercalates into DNA and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Potent Inhibition of the Growth and Induction of Apoptosis of Mantle Cell Lymphoma By the Novel Anthracycline Berubicin in Vitro and in Vivo
Rituximab in combination with hyperfractionated cyclophosphamide, vincristine, doxorubicin (DOX), and dexamethasone has been a… 
2010
2010
572 Berubicin, a topoisomerase II poison with high CNS uptake, inhibits cell growth and induces apoptosis in diffuse large B-cell lymphomas
2010
2010
577 Berubicin, a novel mechanistically altered anthracycline potently inhibits cell growth and induces apoptosis in mantle cell lymphoma
2008
2008
Berubicin, a brain tumor targeting anthracycline: Discovery and clinical evaluation
LB-303 Abstract LB-303 is scheduld in a Late-Breaking Abstract session and is embargoed until Friday, April 11. It will be posted… 
2008
2008
Abstract LB-303: Berubicin, a brain tumor targeting anthracycline: Discovery and clinical evaluation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)